Managing patent foramen ovale in COVID-19 patients during and after viral infection: an unresolved matter

Affiliations

¹ Division of Cardiology Section of Adult Congenital Heart Disease Interventions, Rovigo General Hospital, Rovigo.
² University of Ferrara, School of Medicine, Ferrara, Italy.

Editorial

Gianluca Rigatelli et al. J Cardiovasc Med (Hagerstown). 2021.

. 2021 Apr 1;22(4):259-260.

doi: 10.2459/JCM.0000000000001163.

¹ Division of Cardiology Section of Adult Congenital Heart Disease Interventions, Rovigo General Hospital, Rovigo.
² University of Ferrara, School of Medicine, Ferrara, Italy.

No abstract available

References

1. Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020; 38:1504–1507.
1. Nopp S, Moik F, Jilma B, Pabinger I, Ay C. Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Res Pract Thromb Haemost 2020; 4:1178–1191.
1. Ranard LS, Fried JA, Abdalla M, et al. Approach to acute cardiovascular complications in COVID-19 infection. Circ Heart Fail 2020; 13:e007220.
1. Rigatelli G. Should we consider patent foramen ovale and secundum atrial septal defect as different steps of a single anatomo-clinical continuum? J Geriatr Cardiol 2014; 11:177–179.
1. Lhéritier G, Legras A, Caille A, et al. Prevalence and prognostic value of acute cor pulmonale and patent foramen ovale in ventilated patients with early acute respiratory distress syndrome: a multicenter study. Intensive Care Med 2013; 39:1734–1742.